Zymeworks BC Inc (NASDAQ: ZYME) is -35.52% lower on its value in year-to-date trading and has touched a low of $7.97 and a high of $17.70 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ZYME stock was last observed hovering at around $10.00 in the last trading session, with the day’s loss setting it -0.56%.
Currently trading at $9.44, the stock is -20.21% and -27.03% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.24 million and changing -5.60% at the moment leaves the stock -25.37% off its SMA200. ZYME registered 0.85% gain for a year compared to 6-month loss of -24.66%. The firm has a 50-day simple moving average (SMA 50) of $12.9372 and a 200-day simple moving average (SMA200) of $12.64885.
The stock witnessed a -23.13% gain in the last 1 month and extending the period to 3 months gives it a -33.19%, and is -19.66% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.97% over the week and 6.33% over the month.
Zymeworks BC Inc (ZYME) has around 286 employees, a market worth around $662.19M and $76.30M in sales. Profit margin for the company is -160.80%. Distance from 52-week low is 18.44% and -46.67% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.61%).
with sales reaching $20.65M over the same period.The EPS is expected to shrink by -3.28% this year, but quarterly earnings will post 23.73% year-over-year. Quarterly sales are estimated to grow 105.92% in year-over-year returns.
247.0 institutions hold shares in Zymeworks BC Inc (ZYME), with institutional investors hold 101.46% of the company’s shares. The shares outstanding are 68.96M, and float is at 67.30M with Short Float at 8.03%. Institutions hold 101.28% of the Float.
The top institutional shareholder in the company is ECOR1 CAPITAL, LLC with over 13.44 million shares valued at $114.35 million. The investor’s holdings represent 17.59 of the ZYME Shares outstanding. As of 2024-06-30, the second largest holder is BVF INC/IL with 5.87 million shares valued at $49.95 million to account for 7.684 of the shares outstanding. The other top investors are REDMILE GROUP, LLC which holds 5.21 million shares representing 6.8214 and valued at over $44.35 million, while MORGAN STANLEY holds 5.5496 of the shares totaling 4.24 million with a market value of $36.08 million.
Zymeworks BC Inc (ZYME) Insider Activity
The most recent transaction is an insider purchase by EcoR1 Capital, LLC, the company’s Director. SEC filings show that EcoR1 Capital, LLC bought 196,438 shares of the company’s common stock on Apr 04 ’25 at a price of $11.17 per share for a total of $2.19 million. Following the purchase, the insider now owns 17.7 million shares.
Zymeworks BC Inc disclosed in a document filed with the SEC on Apr 03 ’25 that EcoR1 Capital, LLC (Director) bought a total of 120,770 shares of the company’s common stock. The trade occurred on Apr 03 ’25 and was made at $11.84 per share for $1.43 million. Following the transaction, the insider now directly holds 17.5 million shares of the ZYME stock.
Still, SEC filings show that on Apr 02 ’25, EcoR1 Capital, LLC (Director) acquired 74,360 shares at an average price of $11.85 for $0.88 million. The insider now directly holds 17,382,566 shares of Zymeworks BC Inc (ZYME).
